The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,170.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.171%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,170.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement of share repurchase programme

5 Mar 2024 07:01

RNS Number : 5484F
Hiscox Ltd
05 March 2024
 

 

Announcement of share repurchase programme

 

Hamilton, Bermuda (5 March 2024) - Hiscox Ltd ("Hiscox" or the "Company") today announces it will commence a buyback of its ordinary shares of 6.5 pence each ("Ordinary Shares") for a maximum aggregate consideration of $150 million (the "Programme"), in order to return additional capital to shareholders. The Programme will commence today with an initial tranche of $75 million.

 

Hiscox has entered into a non-discretionary agreement with Peel Hunt LLP ("Peel Hunt") to conduct the initial tranche of the Programme with the Company subsequently purchasing its Ordinary Shares from Peel Hunt. Under this arrangement, Peel Hunt will act as principal and make trading decisions independently of Hiscox, except for Hiscox's ability to terminate Peel Hunt's mandate in certain limited circumstances.

 

The maximum aggregate consideration under the initial tranche is $75 million (excluding expenses). The Company intends to cancel such Ordinary Shares purchased. The sole purpose of the Programme is to reduce Hiscox's share capital.

 

Purchases under the Programme will take place in open market transactions and may be made from time to time by Peel Hunt, depending on market conditions, share price and trading volumes. The Programme will be effected under the authority granted by shareholders at the Company's 2023 Annual General Meeting held on 11 May 2023 (and any subsequent authority) and, as at the date of this announcement, the maximum number of shares that may be repurchased under the Programme is 34,655,073 Ordinary Shares. Any purchases contemplated by this announcement will be carried out on the London Stock Exchange and/or other recognised investment exchange(s). The Programme's initial tranche will end when the maximum aggregate consideration reaches $75 million or as otherwise terminated.

 

The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 as it forms part of UK law pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as applicable laws and the regulations of the UK Financial Conduct Authority (including Chapter 12 of the Listing Rules). Any repurchase of shares will be announced no later than 7:30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

There is no guarantee that the Programme will be implemented in full.

 

The Company intends to enter into arrangements to commence a second tranche of the share buyback programme with Citigroup Global Markets Limited for a maximum aggregate consideration of $75 million in due course.

 

Aki Hussain, Group Chief Executive Officer, Hiscox Ltd, commented:

 

"Our business delivered record profits of $625.9 million and ROE of 21.8%[1] in 2023. This excellent result has led to very strong capital generation, which we are deploying for further growth in all parts of the business in addition to a special return to shareholders of $150 million. The buyback will commence immediately and illustrates our objective of delivering strong returns to our shareholders."

 

ENDS

 

 

For further information

Investors and analysts

Yana O'Sullivan, Director of Investor Relations, London +44 (0)20 3321 5598

Marc Wetherhill, Group Company Secretary, Bermuda +1 441 278 8300

 

Media

Eleanor Orebi Gann, Group Director of Communications, London +44 (0)20 7081 4815

Simone Selzer, Brunswick +44 (0)20 7404 5959

Tom Burns, Brunswick +44 (0)20 7404 5959

Notes to editors

About The Hiscox Group

Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. 

The Hiscox Group employs over 3,000 people in 14 countries, and has customers worldwide. Through the retail businesses in the USA, UK, Europe and Asia, we offer a range of specialist insurance products in commercial and personal lines. Internationally-traded, bigger-ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.

Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

 


[1]Excludes impact of Bermuda Deferred Tax Asset.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKQBDBBKBDNK
Date   Source Headline
22nd Nov 20219:00 amRNSHiscox appoints new Independent Non Exec Director
18th Nov 20219:00 amRNSHiscox announces Liz Breeze as interim Group CFO
2nd Nov 20217:00 amRNSTrading Statement
1st Nov 202111:12 amRNSTotal Voting Rights
7th Oct 20213:27 pmRNSPDMR Shareholding
4th Oct 20214:10 pmRNSDirector / PDMR Shareholding
1st Oct 20214:52 pmRNSTotal Voting Rights
28th Sep 20213:31 pmRNSDirector/PDMR Shareholding
22nd Sep 20213:14 pmRNSDirector/PDMR Shareholding
20th Sep 202111:40 amRNSApplication to be Admitted to Official List
16th Sep 20215:11 pmRNSDirector / PDMR Shareholding
7th Sep 20215:11 pmRNSAnnouncement of Scrip Reference Share Price
1st Sep 202112:57 pmRNSTotal Voting Rights
6th Aug 20212:50 pmRNSTR-1:Standard form - notification major holdings
5th Aug 20212:40 pmRNSTR-1:Standard form notification major shareholding
4th Aug 20214:16 pmRNSTR-1:Standard form notification of major holdings
3rd Aug 20217:01 amRNSInterim Results
3rd Aug 20217:00 amRNSSyndicates 33 and 6104 – results and estimates
2nd Aug 20211:53 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSAki Hussain to succeed Bronek Masojada as CEO
1st Jul 202112:36 pmRNSTotal Voting Rights
30th Jun 202112:44 pmRNSTR-1 Standard form-notification major shareholding
28th Jun 20215:17 pmRNSResult of Meeting
14th Jun 20211:18 pmRNSDirector/PDMR Shareholding
7th Jun 20211:41 pmRNSTR-1:Standard form notification major shareholding
4th Jun 20212:27 pmRNSDirector/PDMR Shareholding
3rd Jun 20211:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202110:30 amRNSNotice of Meeting
3rd Jun 202110:30 amRNSConsent Solicitation
3rd Jun 20217:00 amRNSLegacy Reinsurance Deal
1st Jun 202111:46 amRNSTotal Voting Rights
14th May 20217:00 amRNSAGM Results
13th May 202112:33 pmRNSSyndicates 33 and 6104 – results and estimates
5th May 20217:00 amRNSTrading Statement
20th Apr 202111:51 amRNSDirector/PDMR Shareholding
16th Apr 202112:47 pmRNSDirector/PDMR Shareholding
13th Apr 202111:41 amRNSNotice of 2021 Annual General Meeting
12th Apr 20212:57 pmRNSDirector/PDMR Shareholding
1st Apr 20213:55 pmRNSTotal Voting Rights
24th Mar 20217:00 amRNSDirector/PDMR Shareholding
22nd Mar 202112:49 pmRNSDirector/PDMR Shareholding
17th Mar 20217:00 amRNS2020 Annual Report
15th Mar 20216:28 pmRNSDirector/PDMR Shareholding
15th Mar 20216:13 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSTR-1:Standard form-notification major shareholding
3rd Mar 20217:01 amRNSFull Year Results
3rd Mar 20217:00 amRNSSyndicates 33 and 6104 – results and estimates
27th Jan 202111:21 amRNSTR-1:Standard form-notification major shareholding
15th Jan 202110:40 amRNSHiscox Ltd response to Supreme Court Judgment
11th Jan 20211:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.